Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Sundaram

Showing results (281-290 of 295) with videos related to

Pageof 30
Sort By:
Influenza and Other Respiratory Viruses|November 28, 2025
The Epidemiology, Phylogeny, and Strain Antigenicity of an Influenza A/H3N2 Virus Outbreak Among Vaccinated US Navy MidshipmenSimon D Pollett, Emily Hone, Stephanie A Richard, et al.
Nature Communications|August 24, 2019
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in gliomaNathan R Fons, Ranjini K Sundaram, Gregory A Breuer, et al.
Molecular Cancer Research : MCR|July 1, 2024
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ DepletionKatelyn J Noronha, Karlie N Lucas, Sateja Paradkar, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Magnetoencephalography Reveals Neuroprotective Effects of COVID-19 Vaccination in Non-Human PrimatesJennifer R Stapleton-Kotloski, Jared A Rowland, April T Davenport, et al.
NEJM Evidence|December 17, 2025
Influenza Virus Characteristics in Department of Defense Populations, 2024-2025Anthony C Fries, Kayla M Septer, William E Gruner, et al.
Journal of the American Chemical Society|May 30, 2024
Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain CancersEric D Huseman, Anna Lo, Olga Fedorova, et al.
NAR Cancer|July 28, 2021
Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicitySophia Gayle, Robert Aiello, Nalin Leelatian, et al.
Science Translational Medicine|February 3, 2017
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivityParker L Sulkowski, Christopher D Corso, Nathaniel D Robinson, et al.
NAR Cancer|December 10, 2021
Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'Sophia Gayle, Robert Aiello, Nalin Leelatian, et al.
Human Vaccines & Immunotherapeutics|November 14, 2024
A randomized clinical trial of the impact of melatonin on influenza vaccine: Outcomes from the melatonin and vaccine response immunity and chronobiology study (MAVRICS)Rachel U Lee, Nora L Watson, Gena L Glickman, et al.
Pageof 30

Showing results (281-290 of 295) with videos related to

Sort By:
Pageof 30
Influenza and Other Respiratory Viruses|November 28, 2025
The Epidemiology, Phylogeny, and Strain Antigenicity of an Influenza A/H3N2 Virus Outbreak Among Vaccinated US Navy MidshipmenSimon D Pollett, Emily Hone, Stephanie A Richard, et al.
Nature Communications|August 24, 2019
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in gliomaNathan R Fons, Ranjini K Sundaram, Gregory A Breuer, et al.
Molecular Cancer Research : MCR|July 1, 2024
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ DepletionKatelyn J Noronha, Karlie N Lucas, Sateja Paradkar, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Magnetoencephalography Reveals Neuroprotective Effects of COVID-19 Vaccination in Non-Human PrimatesJennifer R Stapleton-Kotloski, Jared A Rowland, April T Davenport, et al.
NEJM Evidence|December 17, 2025
Influenza Virus Characteristics in Department of Defense Populations, 2024-2025Anthony C Fries, Kayla M Septer, William E Gruner, et al.
Journal of the American Chemical Society|May 30, 2024
Mechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain CancersEric D Huseman, Anna Lo, Olga Fedorova, et al.
NAR Cancer|July 28, 2021
Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicitySophia Gayle, Robert Aiello, Nalin Leelatian, et al.
Science Translational Medicine|February 3, 2017
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivityParker L Sulkowski, Christopher D Corso, Nathaniel D Robinson, et al.
NAR Cancer|December 10, 2021
Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'Sophia Gayle, Robert Aiello, Nalin Leelatian, et al.
Human Vaccines & Immunotherapeutics|November 14, 2024
A randomized clinical trial of the impact of melatonin on influenza vaccine: Outcomes from the melatonin and vaccine response immunity and chronobiology study (MAVRICS)Rachel U Lee, Nora L Watson, Gena L Glickman, et al.
Pageof 30